Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Anti-Cancer Drugs|June 5, 2002
Effects of tamoxifen on human squamous cell carcinoma lines of the head and neckThomas K Hoffmann, Hans Bojar, Jürgen Eckel, et al.
The Journal of Investigative Dermatology|May 18, 2007
ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosisAlireza Mirmohammadsadegh, Rodrigo Mota, Annett Gustrau, et al.
Anticancer Research|May 17, 2002
Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gammaChristian Liebau, Axel W A Baltzer, Sebastian Schmidt, et al.
Cytokines, Cellular & Molecular Therapy|December 9, 2003
Interleukin-12 and interleukin-18 change ICAM-I expression, and enhance natural killer cell mediated cytolysis of human osteosarcoma cellsChristian Liebau, Harry Merk, Sebastian Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profilesOlga Modlich, Hans-Bernd Prisack, Gerald Pitschke, et al.
Anticancer Research|January 18, 2003
rIL-18 triggered gene therapy based on a transduction with the IL-12 plasmid: a new option as immuno-therapy for osteosarcoma?Christian Liebau, Harry Merk, Christian Roesel, et al.
Anticancer Research|November 3, 2004
Immunotherapy by gene transfer with plasmids encoding IL-12/IL-18 is superior to IL-23/IL-18 gene transfer in a rat osteosarcoma modelChristian Liebau, Christian Roesel, Sebastian Schmidt, et al.
The Journal of Investigative Dermatology|June 3, 2006
STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinasesAlireza Mirmohammadsadegh, Mohamad Hassan, Walter Bardenheuer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and predictionJan C Brase, Marcus Schmidt, Thomas Fischbach, et al.
European Journal of Medical Research|February 5, 2014
Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot studyChristiane Matuschek, Marcus Lehnhardt, Peter Arne Gerber, et al.
Pageof 3